Postpartum depression drug needs to be available in Canada 'ASAP', experts say - National

The approval of a fast-acting medication in the U.S. to treat postpartum depression has health experts hoping Canadians will soon have access to the same treatment.

Related Keywords

Canada ,Chicago ,Illinois ,United States ,Lebanon ,Toronto ,Ontario ,Chapel Hill ,Canadian ,American ,Diane Francoeur ,Carole Dagher ,Society Of Obstetricians ,University Of Toronto ,Feinstein Institutes Of Medical Research ,Mental Health ,Health Canada ,Public Health Agency Of Canada ,Centre For Addiction ,Drug Administration ,Sage Therapeutics ,American Journal ,New York Based Feinstein Institutes ,Public Health Agency ,Mount Sinai Hospital ,Postpartum Depression ,Ostpartum Depression Canada ,Ostpartum Depression Drug ,Ostpartum Depression Drugbcanada ,Ostpartum Depression Medication ,Postpartum Depression Pill ,Pd ,Opd Drug ,Pd Drug Canada ,Pd Medciation ,Pd Pill ,Zuranolone ,Uranolone Canada ,Health ,